Page last updated: 2024-08-23

dobutamine and du-21220

dobutamine has been researched along with du-21220 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunn, WJ; Wold, S1
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Brikas, P; Buéno, L; Fioramonti, J2
Berlin, I; Danjou, P; Guillemant, S; Puech, AJ; Touitou, Y1

Trials

1 trial(s) available for dobutamine and du-21220

ArticleYear
Beta-adrenoceptor agonists do not stimulate daytime melatonin secretion in healthy subjects. A double blind placebo controlled study.
    Life sciences, 1995, Mar-17, Volume: 56, Issue:17

    Topics: Adrenergic beta-Agonists; Adult; Albuterol; Cross-Over Studies; Dobutamine; Double-Blind Method; Female; Humans; Male; Melatonin; Ritodrine

1995

Other Studies

5 other study(ies) available for dobutamine and du-21220

ArticleYear
Structure-activity study of beta-adrenergic agents using the SIMCA method of pattern recognition.
    Journal of medicinal chemistry, 1978, Volume: 21, Issue:9

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anura; In Vitro Techniques; Models, Biological; Receptors, Adrenergic, beta; Structure-Activity Relationship

1978
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Central and peripheral beta-adrenergic control of gastrointestinal motility in sheep.
    Reproduction, nutrition, development, 1990, Volume: Suppl 2

    Topics: Animals; Dobutamine; Gastrointestinal Motility; Intestine, Small; Ritodrine; Sheep; Stomach, Ruminant

1990
Central and peripheral beta-adrenergic influences on reticulo-rumen and upper-gut myoelectrical activity in sheep.
    Journal of veterinary pharmacology and therapeutics, 1989, Volume: 12, Issue:4

    Topics: Acebutolol; Animals; Dobutamine; Duodenum; Electromyography; Female; Gastrointestinal Motility; Intestine, Small; Isoproterenol; Jejunum; Propranolol; Receptors, Adrenergic, beta; Reticulum; Ritodrine; Rumen; Sheep

1989